Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma

B and T lymphocyte attenuator (BTLA) is a newly identified immune checkpoint molecular belonging to the CD28 immunoglobulin superfamily. However, the expression and clinical value of BTLA in skin cutaneous melanoma (SKCM) has not been widely characterized. We found that BTLA levels were upregulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xubin, Song, Jingjing, Chen, Buran, Qi, Yufeng, Jiang, Wenjie, Li, Huihui, Zheng, Danni, Wang, Yinghao, Zhang, Xiaohua, Liu, Haiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953043/
https://www.ncbi.nlm.nih.gov/pubmed/33718105
http://dx.doi.org/10.3389/fonc.2020.592811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953043/
https://www.ncbi.nlm.nih.gov/pubmed/33718105
http://dx.doi.org/10.3389/fonc.2020.592811

Ejemplares similares